Top
Trimedyne
The Leader in Cost-Effective Laser Technology

Home | About Us | Products | Education and Training | Investor Relations | Events

Company Profile | Current Price | SEC Filings | Financial Information | Donner Analysis of Trimedyne

 | Laser Spine Therapy Provider List |

 

SEC Filings

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-QSB
QUARTERLY REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
THIRD QUARTER, FISCAL YEAR 2005
FOR THE QUARTER ENDED JUNE 30, 2005

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-QSB
QUARTERLY REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
SECOND QUARTER, FISCAL YEAR 2005
FOR THE QUARTER ENDED MARCH 31, 2005

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-QSB
QUARTERLY REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
FIRST QUARTER, FISCAL YEAR 2005
FOR THE QUARTER ENDED DECEMBER 31, 2004

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDED FORM 10-KSB
ANNUAL REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2004

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDMENT 1 FORM 10-QSB
QUARTERLY REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
THIRD QUARTER, FISCAL YEAR 2004
FOR THE QUARTER ENDED JUNE 30, 2004

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDMENT 1 FORM 10-QSB
QUARTERLY REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
SECOND QUARTER, FISCAL YEAR 2004
FOR THE QUARTER ENDED MARCH 31, 2004

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
SEC Form 4, 2004-03-15.

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDMENT 1 FORM 10-QSB
QUARTERLY REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
FIRST QUARTER, FISCAL YEAR 2004
FOR THE QUARTER ENDED DECEMBER 31, 2003

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
SEC Form 4, 2003-11-12.

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDED FORM 10-KSB
ANNUAL REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2003

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDMENT 1 FORM 10-QSB
QUARTERLY REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
THIRD QUARTER, FISCAL YEAR 2003
FOR THE QUARTER ENDED JUNE 30, 2003

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDMENT 1 FORM 10-QSB
QUARTERLY REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
SECOND QUARTER, FISCAL YEAR 2003
FOR THE QUARTER ENDED MARCH 31, 2003

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDMENT 1 FORM 10-QSB
QUARTERLY REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
FIRST QUARTER, FISCAL YEAR 2003
FOR THE QUARTER ENDED DECEMBER 31, 2002

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDED FORM 10-KSB
ANNUAL REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2002

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
SEC Form 4, 2002-08-29.

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDMENT 1 FORM 10-QSB/A
QUARTERLY REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
THIRD QUARTER, FISCAL YEAR 2002
FOR THE QUARTER ENDED JUNE 30, 2002

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDMENT 1 FORM 10-QSB/A
QUARTERLY REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
SECOND QUARTER, FISCAL YEAR 2002
FOR THE QUARTER ENDED MARCH 31, 2002

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDMENT 1 FORM 10-QSB/A
QUARTERLY REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
FIRST QUARTER, FISCAL YEAR 2002
FOR THE QUARTER ENDED DECEMBER 31, 2001


For more information go to www.sec.gov

 

Top of Page

 

Home | About Us | Products | Education & Training | Investor Relations | Events
What's New | Careers | DoublePulse | Site Map | Contact Us

© Copyright 2001 - 2005 Trimedyne, Inc.  All rights reserved.